Oragenics raises $4.45M in public offering; sold shares and pre-funded warrants at $0.55

ORAGENICS INC

Gross proceeds of ~$4.45M from offering of 3,078,378 shares and 5,028,206 pre-funded warrants.
Net proceeds ~$3.79M after placement agent fees (7%) and estimated expenses.
Proceeds to fund ONP-002 development for mild traumatic brain injury and general working capital.
Post-offering shares outstanding: 8,659,071 common shares plus 5,028,206 pre-funded warrants.
Placement agent Dawson James receives 7% cash fee and warrants for 5% of securities sold at 125% of offering price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.